Objective: The effect of arabinogalactan on immune function in mice has been systematically studied to provide experimental and theoretical basis for clinical and food development and application. Method: Kunming mice were randomly divided into four groups, and a mouse immunosuppressive model was established using cyclophosphamide as a tool drug. Blood routine, immune organs, liver cell physiological sections, and antigen physiological indicators (AST, ALT, MDA, TNF) in the blood were measured- α And IL- β). In vitro lymphocyte proliferation and transformation were also evaluated. Result: We successfully established a cyclophosphamide-induced immunosuppressive mouse model. In the arabinogalactan-treated and the cyclophosphamide-treated groups, increases were observed in body weight, thymus and spleen weight, red blood cells, white blood cells, and lymphocytes. The results of liver tissue sectioning and physiological index analysis showed that the arabinogalactan group could positively regulate various indicators compared to the control group, with significant differences; The positive regulation of arabinogalactan and cyclophosphamide groups was significant compared to the cyclophosphamide group, and the difference was extremely significant; The single use of arabinogalactan has the best effect on various indicators in mice. Conclusion: Arabinogalactan has an antagonistic effect on immunosuppressants, improves various indicators of mouse immune function, and has the effect of enhancing mouse immune function.
This research investigated the potential pharmacological mechanism of Bazhen decoction in the treatment of depression utilizing network pharmacology and molecular docking techniques. The study selected 160 effective active ingredients and their 4775 related targets in Bazhen decoction through the Traditional Chinese Medicine Systems Pharmacology Database (TCMSP), and with further analysis identified 270 potential targets for Bazhen decoction's anti-depressive effect. Cytoscape software helped construct an active ingredient-target network and protein-protein interaction(PPI)network, revealing core targets and key biological processes. GO function pathway enrichment analysis showed that biological processes with respect to the decoction’s anti-depressive effect mainly involves response to lipopolysaccharides, aging, and positive regulation of the apoptotic process. KEGG pathway analysis demonstrated that the primary pathways affected by Bazhen decoction include neuroactive ligand-receptor interaction, cAMP signaling pathway, etc. Molecular docking analysis indicated that key compounds in ginsenosides, among others, have good binding ability with key targets like TP53, providing molecular evidence for the anti-depressive effect. In conclusion, this research confirms that Bazhen decoction exerts anti-depressive effects through multiple components, targets and pathways, providing a scientific basis for its application in the treatment of depression and theoretical support for subsequent basic research and clinical applications.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.